In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antula Healthcare AB

Division of Healthcare Brands International Ltd.
www.antula.se

Latest From Antula Healthcare AB

Meda Pumps Up Iron With Feosol Relaunch, Revamps Neglected OTCs

Meda Consumer Healthcare is relaunching the Feosol iron supplement brand with three SKUs and aims to become the clear No. 1 brand in the category. Meda’s Swedish parent company prioritizes OTC growth through brand acquisitions and increased marketing resources.

Consumer North America

Meda Pumps Up Iron With Feosol Relaunch, Revamps Neglected OTCs

Meda Consumer Healthcare is relaunching the Feosol iron supplement brand with three SKUs and aims to become the clear No. 1 brand in the category. Meda’s Swedish parent company prioritizes OTC growth through brand acquisitions and increased marketing resources.

Consumer North America

In Brief

GSK comments on nicotine’s status; Perrigo launches formula; NAI sales up with licensing revenue; Japanese star anise is adulterant; POMx for sale; toothpaste nurdle suit settled; Virility Max recalled

Consumer North America

Medical Device and In Vitro Diagnostics/Research Deals Statistics Quarterly, Q2 2011

During the second quarter of 2011, 57 medical device companies brought in a total of $1.7 billion in financings. The M&A activity reached $28.8 billion, unusually high due to Johnson & Johnson's $21.7 billion takeover of orthopedic device maker Synthes. VC funding represented $76 million or 43% of the second quarter's in vitro diagnostics/research financing aggregate of $177 million. A hefty $4.1 billion was spent on 11 in vitro diagnostic/research M&A transactions, the largest being Thermo Fisher's $3.5 billion buy of Swedish genetics testing firm Phadia AB.
Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • Healthcare Brands International Ltd.
  • Senior Management
  • Contact Info
  • Antula Healthcare AB
    Phone: 08-31 68 00
    Östermalmsgatan 1
    Stockholm, 114 26
    Sweden
Advertisement
Advertisement
UsernamePublicRestriction

Register